estudio soul semaglutide ACC 25 Late-Breaking Discussion: SOUL: in Patients with T2D Oral Semaglutide and Cardiovascular Outcomes

Name: estudio soul semaglutide ACC 25 Late-Breaking Discussion: SOUL: in Patients with T2D Oral Semaglutide and Cardiovascular Outcomes
Brand: matisco.be
SKU: 26384603286
Price: 27.41 USD
Availability: InStock
Rating: 4.680400000000001 (29 reviews)

SKU: 26384603286

4.7

DKK27.41 DKK58.41

Pay in 4 interest-free payments of $6.85 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Live Spec

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes New England Journal of Medicine Comenta SURPASS y te envo el resumen completo del artculo Acaba de salir el post hoc del SURPASS CVOT en JAMA Cardiology y necesitas el contexto para entenderlo. La SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients Estudio SOUL: Semaglutide oral reduce un 14% eventos cardiovasculares mayores en diabetes tipo 2

Store: matisco.be · Domain: matisco.be

Description

The trials did not show dramatic muscle loss in well-nourished participants, but this was not the primary outcome measured, and individual dietary behaviour varies significantly outside controlled trial conditions